Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04950010 · ClinicalTrials.gov registry record · NA
High-intensity Exercise After Treatment
A NA study, sponsored by University of Nebraska.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04950010: Clinical Trial NA study, sponsored by University of Nebraska.
NCT04950010 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04950010, a NA study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This pilot study tests the feasibility and preliminary efficacy of an 8-week, 3-arm pilot exercise trial in which 45 breast cancer survivors will be randomized to high-intensity interval training (HIIT; n=15), moderate-intensity aerobic training (MOD; n=15), or Usual Care (UC; n=15).
Primary Outcome
Sample size / \[1-(#ineligible/# exposed to recruitment)\*(#exposed to recruitment)\]
Interventions
- BEHAVIORAL High-Intensity Interval Training
- BEHAVIORAL Moderate-Intensity Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2022-07-15 |
| Phase | NA |
Why NCT04950010 stopped before completion
NCT04950010 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which High-Intensity Interval Training is the first listed.
NCT04950010 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04950010 about?
NCT04950010 is a clinical study titled "High-intensity Exercise After Treatment". This pilot study tests the feasibility and preliminary efficacy of an 8-week, 3-arm pilot exercise trial in which 45 breast cancer survivors will be randomized to high-intensity interval training (HIIT; n=15), moderate-intensity aerobic training (MOD; n=15), or Usual Care (UC; n=15).
What is the current status of trial NCT04950010?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2022-03-28. Estimated completion is 2022-07-15.
What interventions are being tested in trial NCT04950010?
The interventions under investigation include: High-Intensity Interval Training (BEHAVIORAL), Moderate-Intensity Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT04950010?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04950010's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI